' Good' Cholesterol May Not Be So in Postmenopausal Women
TUESDAY, Aug. 7, 2018 -- Elevated high-density lipoprotein cholesterol (HDL-C) may not always be cardioprotective in postmenopausal women, according to a study published online July 19 in Arteriosclerosis, Thrombosis, and Vascular Biology.
Samar R.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 7, 2018 Category: Pharmaceuticals Source Type: news
E-Cigarette Flavorings May Impair Vascular Function
THURSDAY, June 14, 2018 -- Flavoring additives used in electronic cigarettes (e-cigarettes) may have adverse effects on blood vessels, according to a study published online June 14 in Arteriosclerosis, Thrombosis, and Vascular Biology.
Jessica L.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 14, 2018 Category: Pharmaceuticals Source Type: news
Pitt's David Vorp named Fellow of the American Heart Association
(University of Pittsburgh) David A. Vorp, Associate Dean for Research and John A. Swanson Professor of Bioengineering at the University of Pittsburgh Swanson School of Engineering, was named a Fellow of the American Heart Association (FAHA) in recognition of his innovative and sustained contributions in scholarship, education, and volunteer service to the organization. Vorp's election was conferred by the Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) recognizing his work in those fields. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 4, 2018 Category: International Medicine & Public Health Source Type: news
Scientists Discover a Bone-Deep Risk for Heart Disease
Few doctors, and even fewer patients, have heard of C.H.I.P. But it is emerging as a major cause of heart attacks and stroke, as deadly as high blood pressure or cholesterol. (Source: NYT Health)
Source: NYT Health - January 29, 2018 Category: Consumer Health News Authors: GINA KOLATA Tags: Heart Stem Cells Leukemia Genetics and Heredity Stroke Bone Marrow Blood Arteriosclerosis and Atherosclerosis McCarroll, Steven A (1970- ) Kathiresan, Sekar Walsh, Kenneth Source Type: news
Long-lasting adaptations of the innate immune system through the bone marrow
(Radboud University Nijmegen) The immune system not only detects and destroys pathogens such as microbes but also plays a role in the onset of diseases such as arteriosclerosis. Scientists from Radboud university medical center, Bonn, Dresden and Pennsylvania, studied a new mechanism that regulates the immune system's functioning. They discovered that cholesterol inhibitors may prevent infections, that a high-fat Western diet can have a long-lasting effect on our immunity and that even our stem cells can be disrupted. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - January 11, 2018 Category: Infectious Diseases Source Type: news
Fast food makes the immune system more aggressive in the long term
(University of Bonn) The immune system reacts similarly to a high fat and high calorie diet as to a bacterial infection. This is shown by a study led by the University of Bonn. Unhealthy food seems to make the body's defenses more aggressive in the long term. Even long after switching to a healthy diet, inflammation towards innate immune stimulation is more pronounced. These changes may be involved in the development of arteriosclerosis and diabetes. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - January 11, 2018 Category: Biology Source Type: news
Ra Medical co-founder Burstein touts innovation, planning and caring as keys to success for medtech execs
This year has been an exciting one for Ra Medical, maker of the Dabra arteriosclerosis laser designed to treat peripheral artery disease.
In May, the Carlsbad, Calif.-based company received a nod from the FDA for the Dabra, clearing it for sale in the US – something it had applied for approximately three years prior. And in September, the company revealed plans for a new funding round looking to raise up to $15 million to support the newly cleared technology.
The path to commercialization has been a long, and satisfying, journey for co-founder and executive vice president Melissa Burstein. She credits the company&#...
Source: Mass Device - December 1, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Ra Medical Source Type: news
New way to treat cholesterol may be on the horizon
(Houston Methodist) A breakthrough discovery by scientists at Houston Methodist Research Institute could change the way we treat cholesterol. Researchers found new evidence that challenges a 40-year notion of how fast we eliminate it from our bodies. This accidental discovery reveals a new pathway in the cholesterol-elimination chain that will be key to developing new drugs to lower cholesterol. Their findings are described in the American Heart Association's Arteriosclerosis, Thrombosis, and Vascular Biology journal. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 26, 2017 Category: International Medicine & Public Health Source Type: news
Ra Medical looks to raise $15m
Ra Medical is looking to raise $15 million, having already raised $650,000 in a new round of equity financing, according to an SEC filing posted this week.
Funds already raised in the round came from 3 anonymous investors, with the 1st sale noted on September 5, according to the filing.
The company has not yet said how it plans to spend money in the round.
Ra Medical is aiming for a Feb. 2018 initial public offering, CEO Dean Irwin told MassDevice.com, after having received a nod from the FDA for its Dabra arteriosclerosis laser in May, clearing it for use in the US.
The post Ra Medical looks to raise $15m appeared fir...
Source: Mass Device - September 21, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Ra Medical Source Type: news
MassDevice.com +5 | The top 5 medtech stories for August 25, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. This tissue paper is made from actual organ tissues
Northwestern University researchers have created biomaterials made from animal organs and tissues that could potentially support natural hormone production in young cancer pat...
Source: Mass Device - August 25, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news
Ra Medical CEO Irwin aims for Feb 2018 IPO
In May, Ra Medical received a nod from the FDA for its Dabra arteriosclerosis laser, clearing it for use in the US.
It was a decision the company had been waiting on for approximately 3 years, CEO Dean Irwin told MassDevice.com in an interview, and signaled a significant shift forward.
“In 2014, we submitted to the FDA, and here in 2017, just on May 24th, we received the go ahead to begin marketing in the United States,” Irwin said.
Ra Medical won CE Mark approval in the European Union last October, giving the company time to launch in the region, which it’s been operating in for several months, Irwin said.
“Tha...
Source: Mass Device - August 24, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cardiovascular Regulatory/Compliance Ra Medical Source Type: news
Thieme and Schattauer launch new open access journal TH Open
Thieme has joined forces with Schattauer Publishers to launch a new open access journal: TH Open. It will provide updates on the latest developments in vascular medicine, complementing Schattauer’s established subscription title Thrombosis and Haemostasis. The new open access journal will follow the PWYW (pay what you want) pricing strategy, which leaves the decision of how much the publication of an article in the new English-language journal is worth up to the author. TH Open will be officially introduced at the ISTH 2017 Congress, the global meeting in thrombosis, hemostasis and vascular biology to be held in Berl...
Source: News from STM - July 5, 2017 Category: Databases & Libraries Authors: STM Publishing News Tags: Featured Open Access Source Type: news
Snake venom is key ingredient in experimental antiplatelet drug
An experimental antiplatelet drug has surprising bite. Based on a protein found in snake venom, the new drug prevented blood clotting in mice without causing excessive bleeding after an injury, according to research published Thursday in the journal Arteriosclerosis, Thrombosis and Vascular Biology. The drug has yet to be tested in humans. (Source: CNN.com - Health)
Source: CNN.com - Health - June 8, 2017 Category: Consumer Health News Source Type: news
Snake venom is key ingredient in experimental drug for heart patients
An experimental antiplatelet drug has surprising bite. Based on a protein found in snake venom, the new drug prevented blood clotting in mice without causing excessive bleeding after an injury, according to research published Thursday in the journal Arteriosclerosis, Thrombosis and Vascular Biology. The drug has yet to be tested in humans. (Source: CNN.com - Health)
Source: CNN.com - Health - June 8, 2017 Category: Consumer Health News Source Type: news
Bathroom scales will inform about life threatening conditions
(Kaunas University of Technology) Weighing oneself has become one of the most common morning rituals. However, your weight is not the only message that can be delivered by your bathroom scales: the team of researchers at Kaunas University of Technology (KTU) Institute of Biomedical Engineering are developing the multifunctional scales, which can monitor your health and inform about potentially dangerous life conditions, such as arteriosclerosis or cardiac arrhythmia. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 16, 2017 Category: Biology Source Type: news
